0001669191-20-000840.txt : 20201218 0001669191-20-000840.hdr.sgml : 20201218 20201218091730 ACCESSION NUMBER: 0001669191-20-000840 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20201218 DATE AS OF CHANGE: 20201218 EFFECTIVENESS DATE: 20201218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: C-REVEAL THERAPEUTICS LLC CENTRAL INDEX KEY: 0001834759 IRS NUMBER: 842683676 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383635 FILM NUMBER: 201398137 BUSINESS ADDRESS: STREET 1: 20 CORPORATE PARK DRIVE, UNIT 170/180 CITY: PEMBROKE STATE: MA ZIP: 02359 BUSINESS PHONE: 2026319143 MAIL ADDRESS: STREET 1: 20 CORPORATE PARK DRIVE STREET 2: UNIT 170/180 CITY: PEMBROKE STATE: MA ZIP: 02359 D 1 primary_doc.xml X0708 D LIVE 0001834759 C-REVEAL THERAPEUTICS LLC 20 Corporate Park Drive Unit 170/180 Pembroke MA MASSACHUSETTS 02359 2026319143 DELAWARE None None Limited Liability Company true 2019 Thomas Haag 20 Corporate Park Drive Unit 170/180 Pembroke MA MASSACHUSETTS 02359 Director Promoter Executive Officer There is no clarification needed. Keith Flaherty 20 Corporate Park Drive Unit 170/180 Pembroke MA MASSACHUSETTS 02359 Director Promoter Executive Officer There is no clarification needed. Cyril Benes 20 Corporate Park Drive Unit 170/180 Pembroke MA MASSACHUSETTS 02359 Promoter There is no clarification needed. Mark Cobbold 20 Corporate Park Drive Unit 170/180 Pembroke MA MASSACHUSETTS 02359 Promoter There is no clarification needed. Biotechnology No Revenues 06c false true false true false 5000 LIVINGSTON SECURITIES, LLC 147364 LIVINGSTON SECURITIES, LLC 147364 626 RexCorp Plaza 6th floor, West Tower Uniondale NY NEW YORK 11556 All States 3250000 0 3250000 false 0 159250 true 0 Up to 4.9% of amount raised for a successful offering 0 true true C-REVEAL THERAPEUTICS LLC Thomas Haag Thomas Haag Principal Executive Officer 2020-12-18